scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1600-0609.2009.01280.X |
P698 | PubMed publication ID | 19500138 |
P50 | author | Małgorzata Krawczyk-Kulis | Q125269742 |
Joanna Dziaczkowska | Q125270002 | ||
Jerzy Hołowiecki | Q11724708 | ||
Miroslaw Markiewicz | Q60233376 | ||
Piotr Kuśnierczyk | Q82758549 | ||
Tomasz Czerw | Q88230103 | ||
Sebastian Giebel | Q92489652 | ||
Slawomira Kyrcz-Krzemien | Q114428269 | ||
Aleksandra Hołowiecka-Goral | Q114775716 | ||
P2093 | author name string | Izabela Nowak | |
Jerzy Wojnar | |||
Agnieszka Karolczyk | |||
Malgorzata Kopera | |||
P433 | issue | 4 | |
P304 | page(s) | 343-356 | |
P577 | publication date | 2009-06-02 | |
P1433 | published in | European Journal of Haematology | Q15765799 |
P1476 | title | Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation | |
P478 | volume | 83 |
Q35594106 | A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation |
Q38079585 | Clinical relevance of natural killer cells following hematopoietic stem cell transplantation |
Q64997781 | Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade. |
Q36775731 | Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors |
Q33701536 | Does the KIR2DS5 gene protect from some human diseases? |
Q36061068 | Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation. |
Q37786500 | Natural killer cells and tumor control |
Q41618466 | Role of killer immunoglobulin-like receptor and ligand matching in donor selection |
Q53344984 | Sequential recovery of NK cell receptor repertoire after allogeneic hematopoietic SCT. |
Q38478878 | Therapeutic potential and challenges of natural killer cells in treatment of solid tumors |
Search more.